People

Douglas Hanahan, PhD, director of the Swiss Institute for Experimental Cancer Research in Lausanne, received the American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research in April at the organization's Annual Meeting in San Diego, CA. The award honors his pioneering and lasting contributions to the cancer research community, such as the development of one of the first transgenic mouse models of cancer. In addition, Hanahan has made groundbreaking contributions to the understanding of autoimmunity and tumor microenvironment, and helped establish the field of tumor angiogenesis.

Webster K. Cavenee, PhD, director of the Ludwig Institute for Cancer Research in San Diego and distinguished professor at the University of California, San Diego, received the AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research. Cavenee's pioneering work in retinoblastoma provided indisputable evidence for the existence of tumor suppressor genes in humans. He has also made key contributions to understanding the biology of glioblastoma multiforme, illuminating the molecular mechanisms that drive the growth, migration, and survival of tumor cells and identifying potential new therapies for the disease.

Boris Pasche, MD, PhD, began his new position as director of the Comprehensive Cancer Center at Wake Forest Baptist Medical Center in Winston-Salem, NC, on March 1. Prior to joining Wake Forest, he was a professor of medicine and served as director of the division of hematology/oncology at the University of Alabama Birmingham. As a researcher, he has focused on the role of the TGF-β pathway in cancer development and progression.

For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.